Not Tagged
Not Tagged
['biomarker', 'sarcoma']
there is a need for optimal tyrosine kinase inhibitor combination strategies based on sarcoma subtype to help improve outcomes, said our at #asco23 today. however, the lack of a biomarker (beyond subtype) is a hurdle. learn more: #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789